Considerations and evidence for an ADHD outcome measure

Academic Pediatrics

Volumn 14, Issue 5 SUPPL., 2014, Pages

  Woods, Donna ^a   Wolraich, Mark ^b   Pierce, Karen ^a   Dimarco, Lindsay ^a   Muller, Nicole ^a   Sachdeva, Ramesh ^c,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c AMERICAN ACADEMY OF PEDIATRICS   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

attention deficit hyperactivity disorder; mental health; outcome measures; pediatrics; quality of health care

Indexed keywords

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; HUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; TOTAL QUALITY MANAGEMENT; UNITED STATES;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC; QUALITY IMPROVEMENT; UNITED STATES;

EID: 84906888551     PISSN: 18762859     EISSN: 18762867     Source Type: Journal    
DOI: 10.1016/j.acap.2014.06.011     Document Type: Article

References (52)

1. American Psychiatric Association. DSM-5 Task Force Diagnostic and Statistical Manual of Mental Disorders: DSM-5 5th ed 2013 American Psychiatric Association Washington, DC
2. Bloom B, Cohen RA, Freeman G. Summary Health Statistics for US Children: National Health Interview Survey, 2009. US Department of Health and Human Services; US Centers for Disease Control and Prevention; National Center for Health Statistics. Vital and Health Statistics, ser. 10, no. 247, December 2010. Available at: http://www.cdc.gov/nchs/data/series/sr-10/sr10-247.pdf. Accessed July 3, 2014.
3. Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children - United States, 2003 and 2007 MMWR Morb Mortal Wkly Rep 59 2010 1439 1443
4. M. Wolraich, L. Brown, R.T. Brown Subcommittee on Attention-Deficit/ Hyperactivity Disorder; Steering Committee on Quality Improvement and Management ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents Pediatrics 128 2011 1007 1022
5. American Psychiatric Association; DSM-4 Task Force Diagnostic and Statistical Manual of Mental Disorders: DSM-4-TR 4th rev ed 2000 American Psychiatric Association Washington, DC
6. Agency for Healthcare Research and Quality. CHIPRA pediatric quality measures program. March 2013. Available at: http://www.ahrq.gov/policymakers/ chipra/pqmpback.html. Accessed October 30, 2013.
7. A. Donabedian, and J.C. Attwood An evaluation of administrative controls in medical-care programs N Engl J Med 269 1963 347 354
8. National Quality Forum. Update: NQF endorses mental health outcome measures. PR Newswire, January 2011. Available at: http://www.prnewswire.com/ news-releases/update-nqf-endorses-mental-health-outcome-measures-114737839.html. Accessed October 30, 2013.
9. National Committee for Quality Assurance. Follow-up care for children prescribed ADHD medication. Available at: http://www.ncqa.org/portals/0/Follow- Up%20Care%20for%20Children%20Prescribed%20ADHD%20Medication.pdf. Published 2009. Accessed October 24, 2013.
10. E. Chan, M.R. Hopkins, and J.M. Perrin et al. Diagnostic practices for attention deficit hyperactivity disorder: a national survey of primary care physicians Ambul Pediatr 5 2005 201 208
11. J.L. Rushton, K.E. Fant, and S.J. Clark Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder Pediatrics 114 2004 E23 E28
12. M.L. Wolraich, D. Bard, and M. Stein et al. Pediatricians' attitudes and practices on attention-deficit/hyperactivity disorder (ADHD) before and after the development of ADHD pediatric practice guidelines J Atten Disord 13 2010 563 572
13. R.H. Brook, and K.N. Lohr Efficacy, effectiveness, variations, and quality: boundary-crossing research Med Care 23 1985 710 722
14. J. Mant Process versus outcome indicators in the assessment of health care Int J Qual Health Care 13 2001 475 480
15. HealthIT.gov. Meaningful use definition and objectives. Available at: http://www.healthit.gov/providers-professionals/meaningful-use-definition- objectives. Accessed October 30, 2013.
16. Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA). The PRISMA statement. Available at: www.prisma-statement.org/ statement.htm. Accessed January 15, 2014.
17. Subcommittee on Attention-Deficit/Hyperactivity Disorder Committee on Quality Improvement Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder Pediatrics 108 2001 1033 1044
18. US Preventive Services Task Force. Procedure manual. Available at: http://www.uspreventiveservicestaskforce.org/uspstf08/methods/procmanual4.htm. Accessed October 30, 2013.
19. S.H. Kollins, R. Jain, and M. Brams et al. Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD Pediatrics 127 2011 E1406 E1413
20. T.E. Wilens, J.H. Newcorn, and C.J. Kartochvil et al. Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder J Pediatr 149 2006 112 119
21. R.T. Brown, A. Perwien, and D.E. Faries et al. Atomoxetine in the management of children with ADHD: effects on quality of life and school functioning Clin Pediatr 45 2006 819 827
22. L.A. Wietecha, D.W. Williams, and M. Herbert et al. Atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder J Child Adolesc Psychopharmacol 19 2009 719 730
23. R.L. Findling, A.C. Childress, S. Krishnan, and J.J. McGough Long-term effectiveness and safety of lisdexamfetamine dimesulate in school-aged children with attention-deficit/hyperactivity disorder CNS Spectr 13 2008 614 620
24. L.L. Greenhill, R. Muniz, and R.R. Ball et al. Efficacy and safety of dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder J Am Acad Child Psy 45 2006 817 823
25. H. Quintana, E.A. Cherlin, and D.A. Duesenberg et al. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder - a preliminary tolerability and efficacy study Clin Ther 29 2007 1168 1177
26. P.L. Hazell, M.R. Kohn, and R. Dickson et al. Core ADHD symptom improvement with atomoxetine versus methylphenidate: a direct comparison meta-analysis J Atten Disord 15 2011 674 683
27. F.R. Sallee, J. McGgough, and T. Wigal et al. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial J Am Acad Child Adolesc Psychiatry 48 2009 155 165
28. J.K. Buitelaar, T.E. Wilens, and S. Zhang et al. Comparison of symptomatic versus functional changes in children and adolescents with ADHD during randomized, double-blind treatment with psycho stimulants, atomoxetine, or placebo J Child Psychol Psychiatry 50 2009 335 342
29. L.E. Arnold, R.L. Lindsay, and C.K. Conners et al. A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder J Child Adolesc Psychopharmacol 14 2004 542 554
30. T.M. Durell, A.J. Pumariega, and E.M. Rothe et al. Effects of open-label atomoxetine on African-American and Caucasian pediatric outpatients with attention-deficit/hyperactivity disorder Ann Clin Psychiatry 21 2009 26 37
31. J. Biederman, R.D. Melmed, and A. Patel et al. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder Pediatrics 121 2008 E73 E84
32. R.L. Findling, L.D. Ginsberg, R. Jain, and J. Gao Effectiveness, safety, and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: an open label, dose-optimization study J Child Adolesc Psychopharmacol 19 2009 649 662
33. J.N. Epstein, J.M. Langberg, and P.K. Lichtenstein et al. Community-wide intervention to improve the attention-deficit/hyperactivity disorder assessment and treatment practices of community physicians Pediatrics 122 2008 19 27
34. D.W. Murray, L.E. Arnold, and J. Swanson et al. A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/ hyperactivity disorder (MTA) Curr Psychiatry Rep 10 2008 424 431
35. J. Swanson, L.E. Arnold, and H. Kraemer et al. Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA). Part II: supporting details J Atten Disord 12 2008 15 43
36. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/ hyperactivity disorder Pediatrics 113 2004 754 761
37. D.R. Hatfield, and B.M. Ogles The use of outcome measures by psychologists in clinical practice Prof Psychol Res Pract 35 2004 485 491
38. G. Salvi, M. Leese, and M. Slade Routine use of mental health outcome assessments: choosing the measure Br J Psychiatry 186 2005 146 152
39. M. Slade What outcomes to measure in routine mental health services, and how to assess them: a systematic review Aust N Z J Psychiatry 36 2002 743 753
40. R.C. Hermann, H.S. Leff, and G. Lagodmos Integrating process measures with other types of quality assessment: outcome measurement. In: Selecting Process Measures for Quality Improvement in Mental Healthcare 2002 Center for Mental Health Services Cambridge, Mass
41. C.L. Hall, M. Moldavsky, and L. Baldwin et al. The use of routine outcome measures in two child and adolescent mental health services: a completed audit cycle BMC Psychiatry 13 2013 270
42. T.E. Wilens, K. McBurnett, and O. Bukstein et al. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder Arch Pediatr Adolesc Med 160 2006 82 90
43. L.A. Adler, T. Wilens, and S. Zhang et al. Atomoxetine treatment outcomes in adolescents and young adults with attention-deficit/hyperactivity disorder: results from a post hoc, pooled analysis Clin Ther 34 2012 363 373
44. J.H. Newcorn, V.K. Sutton, M.D. Weiss, and C.R. Sumner Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study J Am Acad Child Psy 48 2009 511 518
45. S. Van der Oord, P.J.M. Prins, J. Oosterlaan, and P.M.G. Emmelkamp Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis Clin Psychol Rev 28 2008 783 800
46. J.Y. Cheng, R.Y. Chen, J.S. Ko, and E.M. Ng Efficacy and safety of atomoxetine for attention-deficity/hyperactivity disorder in children and adolescents - meta-analysis and meta-regression analysis Psychopharmacology 194 2007 197 209
47. G.A. Fabiano, W.E. Pelham, and E.K. Coles et al. A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder Clin Psychol Rev 29 2009 129 140
48. H. Abikoff, L. Hechtman, and R.G. Klein et al. Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment J Am Acad Child Adolesc Psychiatry 43 2004 802 811
49. R. Silva, H.A. Tilker, and J.T. Cecil et al. Open-label study of dexmethylphenidate hydrochloride in children and adolescents with attention deficit hyperactivity disorder J Child Adolesc Psychopharmacol 14 2004 555 563
50. V. Karpenko, J.S. Owens, N.M. Evangelista, and C. Dodds Clinically significant symptom change in children with attention-deficit/hyperactivity disorder: does it correspond with reliable improvement in functioning J Clin Psychol 65 2009 76 93
51. L. Greenhill, S. Kollins, and H. Abikoff et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD J Am Acad Child Adolesc Psychiatry 45 2006 1284 1293
52. D.F. Curtis, S. Chapman, J. Dempsey, and S. Mire Classroom changes in ADHD symptoms following clinic-based behavior therapy J Clin Psychol Med Settings 20 2013 114 122